Arkolith/Insider Trading/UBX/Form 4

Dananberg Jamie

Chief Medical OfficerUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed Apr 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$714
Net Open-Market Flow
-$714
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2023Sell(S)420$1.70$71463K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-010235) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML